Ciesluk, Beata

Erridge, Simon

Sodergren, Mikael H.

Troup, Lucy J.

English

AimsThere is a paucity of research, especially in the UK, which investigates cannabis use patterns, motivations for use, and the negative outcomes in medical cannabis users (MCU), and how this compares to recreational cannabis users (RCU). Therefore, the current study aims to investigate the differences between RCU and MCU in the UK.DesignUsing a cross-sectional survey design, data was collected online using Question-Pro.SettingResearch was conducted between 14.06.2022-14.07.2022 in the community and via medical clinics.ParticipantsParticipants were RCU and MCU currently living in the UK. RCU were invited to take part via social media. MCU were recruited from Sapphire Medical Clinics which provides specialist treatment with cannabis-based medicinal products in the UK.MeasurementThe survey assessed participants’ demographic data, cannabis use frequency, and cannabis use problems (CUDIT-R), PTSD (PCL-5), depression (CES-D), anxiety (STAI), and cannabis use motives (CMMQ).Findings and Conclusions161 participants completed the survey. MCU were significantly older, used cannabis more often and had higher “Sleep” motive (p &lt; 0.05). RCU had significantly higher scores on several motives (e.g., “Enjoyment”, “Coping”) and higher state anxiety scores (p &lt; 0.05). The two groups did not significantly differ on cannabis use problems, and “Low Risk” motive, as well as PTSD, depression, and trait anxiety scores (p &gt; 0.05).The current study demonstrates a significant distinction in use patterns and motivations between RCU and MCU, but also shows areas of potential overlap. These findings hold significant implications for future research, clinical practice, and legislatio

Research Repository and Portal - University of the West of Scotland

 UWS Academic PortalCannabis use in the UKCiesluk, Beata; Erridge, Simon; Sodergren, Mikael H. ; Troup, Lucy J.Published: 03/11/2022Document VersionPeer reviewed versionLink to publication on the UWS Academic PortalCitation for published version (APA):Ciesluk, B., Erridge, S., Sodergren, M. H., & Troup, L. J. (2022). Cannabis use in the UK: a quantitativecomparison of medical and recreational cannabis users. Poster session presented at Society for the Study ofAddiction Annual Conference 2022, Bristol, United Kingdom.General rightsCopyright and moral rights for the publications made accessible in the UWS Academic Portal are retained by the authors and/or othercopyright owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated withthese rights.Take down policyIf you believe that this document breaches copyright please contact pure@uws.ac.uk providing details, and we will remove access to thework immediately and investigate your claim.Download date: 27 Nov 2022Aims There is a paucity of research, especially in the UK, which investigates cannabis use patterns, motivations for use, and the negative outcomes in medical cannabis users (MCU), and how this compares to recreational cannabis users (RCU). Therefore, the current study aims to investigate the differences between RCU and MCU in the UK.  Design  Using a cross-sectional survey design, data was collected online using Question-Pro.  Setting  Research was conducted between 14.06.2022-14.07.2022 in the community and via medical clinics.  Participants  Participants were RCU and MCU currently living in the UK. RCU were invited to take part via social media. MCU were recruited from Sapphire Medical Clinics which provides specialist treatment with cannabis-based medicinal products in the UK.  Measurement  The survey assessed participants’ demographic data, cannabis use frequency, and cannabis use problems (CUDIT-R), PTSD (PCL-5), depression (CES-D), anxiety (STAI), and cannabis use motives (CMMQ).  Findings and Conclusions  161 participants completed the survey. MCU were significantly older, used cannabis more often and had higher “Sleep” motive (p < 0.05). RCU had significantly higher scores on several motives (e.g., “Enjoyment”, “Coping”) and higher state anxiety scores (p < 0.05). The two groups did not significantly differ on cannabis use problems, and “Low Risk” motive, as well as PTSD, depression, and trait anxiety scores (p > 0.05).  The current study demonstrates a significant distinction in use patterns and motivations between RCU and MCU, but also shows areas of potential overlap. These findings hold significant implications for future research, clinical practice, and legislation.   

Cannabis use in the UK:a quantitative comparison of medical and recreational cannabis users

https://myresearchspace.uws.ac.uk/ws/files/31657076/2022_09_05_Ciesluk_et_al_Cannabis_accepted.pdf

Cannabis use in the UK:a quantitative comparison of medical and recreational cannabis users

Abstract

Similar works

Full text

Available Versions

Research Repository and Portal - University of the West of Scotland